All News
NEJM Image Challenge: A patient presented with painful and erythematous plaques on his hands and elbows. Lab examinations showed leukocytosis and thrombocytopenia. What is the diagnosis? https://t.co/kQrNuVmVXg https://t.co/4JGeExCcP7
Links:
NEJM NEJM ( View Tweet)
Sep 26, 2021
Everyone in medical school talks about "see one, do one, teach one," but no one talks about "see one, do one, rotate to a difference service and forget everything."
Shailin Thomas shailinthomas ( View Tweet)
Sep 26, 2021
Check out our latest publication:
The Erratic CRP in Rheumatoid Arthritis (RA). The following thread below will explain the paper. @Janetbirdope @RheumNow https://t.co/OOyCnksDr3
Andy Thompson RheumAndy ( View Tweet)
Sep 26, 2021
Aortitis: Let’s review the differential for #aortitis including Non-Infectious and Infectious Causes!
@febrilepodcast x @RheumOnePagers | created by @MithuRheum @swinndong
#IDTwitter #RheumTwitter #FOAMed https://t.co/pR0iTls4PK
Rheum OnePagers RheumOnePagers ( View Tweet)
Sep 26, 2021
New study on #COVID19Vaccine in autoimmune cytopenias
🩸7.4% had clinically significant ⬇️ in counts
🩸 All successfully managed w/steroids & transfusion
🩸 Mild ⬇️ in 10% AIHA and 20% ITP
⭐️Vaccination safe with close monitoring⭐️
https://t.co/qGZe6LiPKz
AmericanJournalofHematology AjHematology ( View Tweet)
Sep 26, 2021
Maker Trade name Generic
PFIZER Comirnaty Pfizer-BioNTech COVID-19 Vaccine FDA approved
MODERNA Spikevax Moderna COVID-19 Vaccine - EUA currently
J&J (pending) Janssen COVID-19 Vaccine- EUA currently
https://t.co/MM7XiSCczl
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 26, 2021
ICYMI:Maternal and fetal outcomes during the COVID-19 pandemic have not been well studied; yet a new retrospective study from Mexico indicates that during the pandemic maternal mortality increased by nearly 57%, with COVID-19 as the cause in 23% of cases.
https://t.co/BcISK0j3kQ https://t.co/xNiH3Ww0SX
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 26, 2021
ICYMI:
Interested in becoming a rheumatologist? It’s interview season! Dr. Kathryn Dao (@KDAO2011 ) shares tips for the interviewer AND the candidate. #RheumNow #RheumTwitter
https://t.co/eWQs9CwqSm https://t.co/H53eOrdnjt
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 26, 2021
"the biologic clock and career clock are in conflict."
"work and life is not a balance. It's a juggling act... one we have to work at every day"
- Indra Nooyi, former CEO of PepsiCo https://t.co/VL7ayAv4NZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 26, 2021
We are planning out our #ACR21 coverage. Is there anything you’d like to see? #RheumNow
Dr. John Cush RheumNow ( View Tweet)
Sep 26, 2021
New podcast available. Download wherever you get your podcasts. #RheumNow
https://t.co/lV4YiF5xKl https://t.co/slhvn4P4mY
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 25, 2021
ICYMI: Prescribe antimalarial dosages at 5 mg/kg/d or less...A baseline retinal exam w/ optical coherence tomography should be performed w/in 6 mos...to rule out confounding Dz. Pts at low risk for retinopathy do not require annual screening until 5 years. https://t.co/l3sCxP1ncj
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 25, 2021
In case you missed it…
IL-6 Inhibition in Refractory Systemic Sclerosis
https://t.co/52oVpR4XV9 https://t.co/4IRbxIu5GZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 25, 2021
ICYMI:
The EMA has recommended Nucala (mepolizumab) as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA) https://t.co/0aVoDpsvet
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 25, 2021
As I go over this week's podcast, I want to say it—I want a new drug safe enough to use during pregnancy, for PMR, for GVHD, and more. I'm going to cover these, and other topics this week on the podcast.
https://t.co/lV4YiFn8BT https://t.co/tj3jiENqhp
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021
Pooled analysis of the DISCOVER-1 and DISCOVER-2 trials have shown that guselkumab, an IL-23 inhibitor, was effective and safe in psoriatic arthritis (PsA) patients with axial involvement and imaging-confirmed sacroiliitis. #RheumNow
https://t.co/yLCxyC1oLr https://t.co/Uloqx2phlh
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021
The #1 question I get from new consults: “How did I get arthritis?”
Here is my list of 11 drugs (or drug classes) known to cause arthritis or rheumatic disorders (as an unintended consequence). #RheumNow
https://t.co/GsV0Qj9ENr https://t.co/IrTkY5yFdY
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021
Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or steroid prescribing between visit types https://t.co/kscU9CbqVM
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021
Prescribe antimalarial dosages at 5 mg/kg/d or less.... A baseline retinal exam w/ optical coherence tomography should be performed w/in 6 mos...to rule out confounding Dz. Pts at low risk for retinopathy do not require annual screening until 5 years.. https://t.co/l3sCxOJLNJ
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021
Encouraging DBRPCT of Rituximab in #PMR: 116 screened, 49 enrolled, 47 completed: 23 on RTX vs 24 on PBO. Steroid-free remission at 21 wks seen with 11/23 (48%) RTX pts vs 5/24 (21%) on PBO (p=0·049). Infusion Rxns: 10 RTX vs 3 PBO); 1 SAE (PE) on RTX https://t.co/U2ZGNrpi0i
Links:
Dr. John Cush RheumNow ( View Tweet)
Sep 24, 2021